US Stock MarketDetailed Quotes
IOBT IO Biotech
- 0.850
- +0.102+13.64%
Close Nov 27 16:00 ET
- 0.870
- +0.020+2.35%
Post 20:01 ET
56.00MMarket Cap-658P/E (TTM)
0.870High0.721Low791.77KVolume0.740Open0.748Pre Close645.16KTurnover2.84%Turnover RatioLossP/E (Static)65.88MShares2.09852wk High0.77P/B23.67MFloat Cap0.66052wk Low--Dividend TTM27.84MShs Float17.880Historical High--Div YieldTTM19.92%Amplitude0.660Historical Low0.814Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
IO Biotech Stock Forum
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
IO Biotech announced promising Phase 2 results for its cancer vaccine IO102-IO103 combined with KEYTRUDA® in first-line metastatic lung cancer treatment. The study showed a 55% unconfirmed/48% confirmed overall response rate and 8...
loading...
No comment yet